tyrphostin a23 has been researched along with Hyperplasia in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishizaki, M | 1 |
| Muromoto, R | 1 |
| Akimoto, T | 1 |
| Sekine, Y | 1 |
| Kon, S | 1 |
| Diwan, M | 1 |
| Maeda, H | 1 |
| Togi, S | 1 |
| Shimoda, K | 1 |
| Oritani, K | 1 |
| Matsuda, T | 1 |
1 other study available for tyrphostin a23 and Hyperplasia
| Article | Year |
|---|---|
Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
Topics: Animals; Blotting, Western; Calgranulin A; Cell Line; Cytokines; Defensins; Enzyme Inhibitors; Gene | 2014 |